budesonide (Pulmicort)

DRUG3 trials

Sponsors

AstraZeneca, University of Nottingham

Conditions

AsthmaChronic Obstructive Pulmonary Disease

Phase 3

Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD

CompletedNCT00421122

AstraZenecaChronic Obstructive Pulmonary Disease

Start: 2006-09-30End: 2007-11-30Updated: 2009-03-27

Long-Term Safety of Symbicort in Asthmatic Children - SAPLING

CompletedNCT00646529

AstraZenecaAsthma

Start: 2002-07-31End: 2003-10-31Target: 175Updated: 2009-03-30

Phase 4

Low Exhaled NO and ICS in Suspected Asthma

University of NottinghamAsthma

Start: 2016-05-31End: 2018-07-31Target: 165Updated: 2016-05-13